EU agency recommends new oral MS medication, Gilenya®

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

EU agency recommends new oral MS medication, Gilenya®

Postby MSUK » Fri Jan 21, 2011 5:27 am


European regulators recommended approval of Novartis's multiple sclerosis pill Gilenya on Friday, consolidating its lead as the first pill to treat the disease.

The green light from the European Medicines Agency in London follows approval in the United States last month, where it has gone on sale at an average cost of $48,000 per patient a year.

Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.... Read More - ... ageid/1309
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service